Summary

The global tomosynthesis market is projected to reach USD 13,188.32 million by 2035, growing at a CAGR of 11.68% from 2025 to 2035. The global tomosynthesis market revolves around 3D breast imaging systems that are highly advanced and contribute to early cancer detection while reducing the number of false positives compared to conventional mammography.

Increasing Prevalence of Breast Cancer
The rising global burden of breast cancer plays a major role in driving the tomosynthesis market, more than any other factor. With millions of new cases every year, healthcare systems are turning their attention to early and accurate detection as a priority. The increased demand has a direct and immediate effect on the widespread adoption of digital breast tomosynthesis (DBT).

Product & Segment Breakdown
Product
- 2D/3D Combo: Offers dual imaging for improved accuracy.
- 3D-Only: Provides full-depth visualization of breast tissue.
Configuration
- U-Arm: Ensures flexible positioning for precise scans.
- Others: Includes alternative setups for varied workflows.
Application
- Breast Cancer Screening: Used for routine early detection.
- Diagnostic Imaging: Supports detailed assessment of abnormalities.
End-User
- Hospitals and Specialty Clinics: Deliver advanced imaging services daily.
- Diagnostic Imaging Centers: Focus on specialized breast imaging tests.
- Research & Academic Institutes: Support innovation and clinical studies.

Regional Analysis
The escalated worldwide market for tomosynthesis is expanding globally with the help of new cases of breast cancer and the need for precise diagnostic procedures. North America and Europe are status quo with the trend, while the Asia-Pacific is catching up very fast. South America and MEA are slowly but surely progressing, notwithstanding the existing cost barriers.

Technology-Driven Competitive Advantage
Rising breast cancer cases and rapid technological advancements are accelerating global adoption of tomosynthesis systems. The move towards early and preventive diagnosis is a key factor that is strengthening demand not only in hospitals but in other healthcare settings as well.

Key Report Attributes
- Market Size 2024: USD 3,888.72 Million
- Market Size 2035: USD 13,188.32 Million
- CAGR (2025-2035): 11.68%
- Base Year: 2025
- Market Forecast Period: 2025-2035

Industry Segmentations Growth
- By Product: 2D/3D Combo - 11.08%, 3D-Only - 12.46%.
- By Configuration: U-Arm - 12.67%, Others - 10.83%.
- By Application: Breast Cancer Screening - 11.47%, Diagnostic Imaging - 14.75%.
- By End-User: Hospitals and Specialty Clinics - 11.38%, Diagnostic Imaging Centers - 12.81%.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ........... 22
2 MARKET INTRODUCTION ........ 24
2.1 DEFINITION .......... 24
2.2 SCOPE OF THE STUDY ....... 24
2.3 RESEARCH OBJECTIVE ........... 24
2.4 MARKET STRUCTURE ....... 25
3 RESEARCH METHODOLOGY ....... 26
3.1 OVERVIEW ........... 26
3.2 DATA FLOW ......... 28
3.2.1 DATA MINING PROCESS ......... 28
3.3 PURCHASED DATABASE: ....... 29
3.4 SECONDARY SOURCES: ......... 30
3.4.1 SECONDARY RESEARCH DATA FLOW: ......... 31
3.5 PRIMARY RESEARCH: ....... 32
3.5.1 PRIMARY RESEARCH DATA FLOW: ........ 33
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ........ 34
3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ........ 34
3.6 APPROACHES FOR MARKET SIZE ESTIMATION: .......... 35
3.6.1 REVENUE ANALYSIS APPROACH ....... 35
3.7 DATA FORECASTING......... 36
3.7.1 DATA FORECASTING TYPE ........... 36
3.8 DATA MODELING ......... 37
3.8.1 MICROECONOMIC FACTOR ANALYSIS: ........ 37
3.8.2 DATA MODELING: ......... 38
3.9 TEAMS AND ANALYST CONTRIBUTION .......... 40
4 MARKET DYNAMICS ........... 42
4.1 INTRODUCTION ....... 42
4.2 DRIVERS ........... 42
4.2.1 INCREASING PREVALENCE OF BREAST CANCER ......... 42
4.2.2 TECHNOLOGICAL ADVANCEMENTS ....... 43
4.2.3 SHIFT TOWARD EARLY AND PREVENTIVE DIAGNOSIS ........... 43
4.3 RESTRAINTS ......... 44
4.3.1 HIGH EQUIPMENT AND OPERATIONAL COSTS ....... 44
4.3.2 REGULATORY AND APPROVAL CHALLENGES ........ 44
4.4 OPPORTUNITY ......... 45
4.4.1 EXPANSION INTO EMERGING MARKETS ........... 45
4.4.2 GOVERNMENT INITIATIVES AND AWARENESS PROGRAMS ........ 46
5 MARKET FACTOR ANALYSIS ....... 47
5.1 PORTER'S FIVE FORCES MODEL ......... 47
5.1.1 THREAT OF NEW ENTRANTS ........ 47
5.1.2 BARGAINING POWER OF SUPPLIERS ........... 48
5.1.3 THREAT OF SUBSTITUTES ........... 48
5.1.4 BARGAINING POWER OF BUYERS ........... 48
5.1.5 INTENSITY OF RIVALRY .......... 48
5.2 IMPACT OF COVID-19 ON THE GLOBAL TOMOSYNTHESIS MARKET ......... 49
6 GLOBAL TOMOSYNTHESIS MARKET, BY PRODUCT ......... 51
6.1 OVERVIEW ........... 51
6.2 2D/3D COMBO ........... 53
6.3 3D-ONLY .......... 54
7 GLOBAL TOMOSYNTHESIS MARKET, BY CONFIGURATION ....... 55
7.1 OVERVIEW ........... 55
7.2 U-ARM ......... 57
7.3 OTHERS ....... 58
8 GLOBAL TOMOSYNTHESIS MARKET, BY APPLICATION ........ 59
8.1 OVERVIEW ........... 59
8.2 BREAST CANCER SCREENING ........ 61
8.3 DIAGNOSTIC IMAGING ......... 62
9 GLOBAL TOMOSYNTHESIS MARKET, BY END USER ........ 63
9.1 OVERVIEW ........... 63
9.2 HOSPITALS AND SPECIALTY CLINICS ......... 65
9.3 DIAGNOSTIC IMAGING CENTERS....... 66
9.4 RESEARCH & ACADEMIC INSTITUTE .......... 66
10 GLOBAL TOMOSYNTHESIS MARKET, BY REGION ....... 67
10.1 OVERVIEW ........... 67
10.2 NORTH AMERICA ......... 68
10.2.1 US....... 71
10.2.2 CANADA ....... 72
10.3 EUROPE ....... 74
10.3.1 GERMANY .......... 77
10.3.2 FRANCE ........ 78
10.3.3 UK ........... 79
10.3.4 ITALY ....... 81
10.3.5 SPAIN ........... 82
10.3.6 RUSSIA ......... 83
10.3.7 REST OF EUROPE .......... 85
10.4 ASIA PACIFIC ....... 87
10.4.1 CHINA ........... 90
10.4.2 INDIA ....... 91
10.4.3 JAPAN .......... 93
10.4.4 SOUTH KOREA ......... 94
10.4.5 MALAYSIA ......... 95
10.4.6 THAILAND .......... 97
10.4.7 INDONESIA ......... 98
10.4.8 REST OF ASIA PACIFIC....... 99
10.5 SOUTH AMERICA .......... 101
10.5.1 BRAZIL .......... 104
10.5.2 MEXICO ........ 105
10.5.3 ARGENTINA ....... 106
10.5.4 REST OF SOUTH AMERICA ........... 108
10.6 MIDDLE EAST AND AFRICA ....... 110
10.6.1 GCC COUNTRIES........... 113
10.6.2 SOUTH AFRICA ........ 114
10.6.3 REST OF MEA .......... 115
11 COMPETITIVE LANDSCAPE ......... 118
11.1 INTRODUCTION ....... 118
11.2 MARKET SHARE ANALYSIS, 2024 ........ 118
11.3 COMPETITOR DASHBOARD ........... 119
11.4 PUBLIC PLAYERS STOCK SUMMARY ........... 120
11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL ......... 120
11.1 KEY DEVELOPMENTS & GROWTH STRATEGIES ........... 121
11.1.1 PRODUCT LAUNCH ....... 121
11.1.2 SOFTWARE LAUNCH .......... 122
11.1.3 PREMARKET APPROVAL ......... 122
11.1.4 PRODUCT APPROVAL ........ 122
11.1.5 INSTALLATION ........ 123
11.1.6 PARTNERSHIP ......... 123
11.1.7 ACQUISITION .......... 125
11.1.8 EQUITY ......... 126
11.1.9 INNOVATION ........... 126
12 COMPANY PROFILES ......... 127
12.1 HOLOGIC, INC. ......... 127
12.1.1 COMPANY OVERVIEW ........ 127
12.1.2 FINANCIAL OVERVIEW ....... 128
12.1.3 PRODUCTS OFFERED ......... 129
12.1.4 KEY DEVELOPMENTS ......... 129
12.1.5 SWOT ANALYSIS .......... 130
12.1.6 KEY STRATEGIES .......... 131
12.2 GE HEALTHCARE .......... 132
12.2.1 COMPANY OVERVIEW ........ 132
12.2.2 FINANCIAL OVERVIEW ....... 133
12.2.3 PRODUCTS OFFERED ......... 134
12.2.4 KEY DEVELOPMENTS ......... 135
12.2.5 SWOT ANALYSIS .......... 136
12.2.6 KEY STRATEGIES .......... 136
12.3 FUJIFILM HOLDINGS CORPORATION .......... 137
12.3.1 COMPANY OVERVIEW ........ 137
12.3.2 FINANCIAL OVERVIEW ....... 138
12.3.3 PRODUCT OFFERED ........... 139
12.3.4 KEY DEVELOPMENTS ......... 139
12.3.5 KEY STRATEGIES .......... 140
12.4 TRIVITRON HEALTHCARE PRIVATE LIMITED ......... 141
12.4.1 COMPANY OVERVIEW ........ 141
12.4.2 FINANCIAL OVERVIEW ....... 142
12.4.3 PRODUCTS OFFERED ......... 142
12.4.4 KEY DEVELOPMENTS ......... 142
12.4.5 KEY STRATEGIES .......... 143
12.5 PLANMED OY ....... 144
12.5.1 COMPANY OVERVIEW ........ 144
12.5.2 FINANCIAL OVERVIEW ....... 145
12.5.3 PRODUCTS OFFERED ......... 145
12.5.4 KEY DEVELOPMENTS ......... 146
12.5.5 KEY STRATEGIES .......... 146
12.6 SIEMENS HEALTHINEERS ........... 147
12.6.1 COMPANY OVERVIEW ........ 147
12.6.2 FINANCIAL OVERVIEW ....... 148
12.6.3 PRODUCTS OFFERED ......... 149
12.6.4 KEY DEVELOPMENTS ......... 149
12.6.5 SWOT ANALYSIS .......... 150
12.6.6 KEY STRATEGIES .......... 151
12.7 PERKINELMER .......... 152
12.7.1 COMPANY OVERVIEW ........ 152
12.7.2 FINANCIAL OVERVIEW ....... 153
12.7.3 PRODUCTS OFFERED ......... 153
12.7.4 KEY DEVELOPMENTS ......... 153
12.7.5 SWOT ANALYSIS .......... 154
12.7.6 KEY STRATEGIES .......... 154
12.8 CANON MEDICAL SYSTEMS CORPORATION ....... 155
12.8.1 COMPANY OVERVIEW ........ 155
12.8.2 FINANCIAL OVERVIEW ....... 155
12.8.3 PRODUCTS OFFERED ......... 156
12.8.4 KEY DEVELOPMENTS ......... 156
12.8.5 SWOT ANALYSIS .......... 157
12.8.6 KEY STRATEGIES .......... 158
12.9 ANALOGIC CORPORATION ....... 159
12.9.1 COMPANY OVERVIEW ........ 159
12.9.2 FINANCIAL OVERVIEW ....... 159
12.9.3 PRODUCTS OFFERED ......... 160
12.9.4 KEY DEVELOPMENTS ......... 160
12.9.5 KEY STRATEGIES .......... 160
12.10 SHIMADZU CORPORATION ....... 161
12.10.1 COMPANY OVERVIEW ........ 161
12.10.2 FINANCIAL OVERVIEW ....... 162
12.10.3 PRODUCTS OFFERED ......... 163
12.10.4 KEY DEVELOPMENTS ......... 163
12.10.5 KEY STRATEGIES .......... 163
12.11 NP JSC AMICO ........... 164
12.11.1 COMPANY OVERVIEW ........ 164
12.11.2 FINANCIAL OVERVIEW ....... 164
12.11.3 PRODUCTS OFFERED ......... 164
12.11.4 KEY DEVELOPMENTS ......... 165
12.11.5 SWOT ANALYSIS .......... 165
12.11.6 KEY STRATEGIES .......... 165
12.12 VMI MÉDICA ........ 167
12.12.1 COMPANY OVERVIEW ........ 167
12.12.2 FINANCIAL OVERVIEW ....... 167
12.12.3 PRODUCTS OFFERED ......... 167
12.12.4 KEY DEVELOPMENTS ......... 168
12.12.5 SWOT ANALYSIS .......... 168
12.12.6 KEY STRATEGIES .......... 169
12.13 BEMEMS CO., LTD. ........ 170
12.13.1 COMPANY OVERVIEW ........ 170
12.13.2 FINANCIAL OVERVIEW ....... 170
12.13.3 PRODUCTS OFFERED ......... 171
12.13.4 KEY DEVELOPMENTS ......... 171
12.13.5 KEY STRATEGIES .......... 171
12.14 SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD. ........ 172
12.14.1 COMPANY OVERVIEW ........ 172
12.14.2 FINANCIAL OVERVIEW ....... 172
12.14.3 PRODUCTS OFFERED ......... 172
12.14.4 KEY DEVELOPMENTS ......... 173
12.14.5 KEY STRATEGIES .......... 173
12.15 SHENZHEN LANDWIND INDUSTRY CO. .......... 174
12.15.1 COMPANY OVERVIEW ........ 174
12.15.2 FINANCIAL OVERVIEW ....... 174
12.15.3 PRODUCTS OFFERED ......... 174
12.15.4 KEY DEVELOPMENTS ......... 174
12.15.5 KEY STRATEGIES .......... 175
12.16 PAYAMED ELECTRONIC INDUSTRIES CO........ 176
12.16.1 COMPANY OVERVIEW ........ 176
12.16.2 FINANCIAL OVERVIEW ....... 176
12.16.3 PRODUCTS OFFERED ......... 176
12.16.4 KEY DEVELOPMENTS ......... 176
12.16.5 KEY STRATEGIES .......... 177
12.17 MEDICAL TECHNOLOGIES LTD (MTL) ........ 178
12.17.1 COMPANY OVERVIEW ........ 178
12.17.2 FINANCIAL OVERVIEW ....... 178
12.17.3 PRODUCT OFFERED ........... 178
12.17.4 KEY DEVELOPMENTS ......... 179
12.17.5 KEY STRATEGIES .......... 179
12.18 METALTRONICA S.P.A. .......... 180
12.18.1 COMPANY OVERVIEW ........ 180
12.18.2 FINANCIAL OVERVIEW ....... 180
12.18.3 PRODUCT OFFERED ........... 180
12.18.4 KEY DEVELOPMENTS ......... 181
12.18.5 KEY STRATEGIES .......... 181
12.19 LOTUS HEALTHCARE ........ 182
12.19.1 COMPANY OVERVIEW ........ 182
12.19.2 FINANCIAL OVERVIEW ....... 183
12.19.3 PRODUCT OFFERED ........... 183
12.19.4 KEY DEVELOPMENTS ......... 183
12.19.5 KEY STRATEGIES .......... 183
12.20 KONINKLIJKE PHILIPS N.V. ........ 184
12.20.1 COMPANY OVERVIEW ........ 184
12.20.2 FINANCIAL OVERVIEW ....... 185
12.20.3 PRODUCTS OFFERED ......... 186
12.20.4 KEY DEVELOPMENTS ......... 186
12.20.5 SWOT ANALYSIS .......... 187
12.20.6 KEY STRATEGIES .......... 187
12.21 ALLENGERS .......... 188
12.21.1 COMPANY OVERVIEW ........ 188
12.21.2 FINANCIAL OVERVIEW ....... 189
12.21.3 PRODUCTS OFFERED ......... 189
12.21.4 KEY DEVELOPMENTS ......... 189
12.21.5 SWOT ANALYSIS .......... 190
12.21.6 KEY STRATEGIES .......... 190
12.22 IMS GIOTTO S.P.A ......... 191
12.22.1 COMPANY OVERVIEW ........ 191
12.22.2 FINANCIAL OVERVIEW ....... 191
12.22.3 PRODUCTS OFFERED ......... 192
12.22.4 KEY DEVELOPMENTS ......... 192
12.22.5 KEY STRATEGIES .......... 192
12.23 SHENZHEN ANGELL TECHNOLOGY CO., LTD. ......... 193
12.23.1 COMPANY OVERVIEW ........ 193
12.23.2 FINANCIAL OVERVIEW ....... 194
12.23.3 PRODUCT OFFERED ........... 194
12.23.4 KEY DEVELOPMENTS ......... 194
12.23.5 KEY STRATEGIES .......... 194
12.24 KONICA MINOLTA, INC. ........ 195
12.24.1 COMPANY OVERVIEW ........ 195
12.24.2 FINANCIAL OVERVIEW ....... 196
12.24.3 PRODUCTS OFFERED ......... 197
12.24.4 KEY DEVELOPMENTS ......... 197
12.24.5 SWOT ANALYSIS .......... 198
12.24.6 KEY STRATEGIES .......... 199
12.25 ELECTRON CO. ......... 200
12.25.1 COMPANY OVERVIEW ........ 200
12.25.2 FINANCIAL OVERVIEW ....... 200
12.25.3 PRODUCTS OFFERED ......... 201
12.25.4 KEY DEVELOPMENTS ......... 201
12.25.5 KEY STRATEGIES .......... 201
13 DATA CITATIONS ........... 202

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 39
TABLE 2 GLOBAL TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 52
TABLE 3 GLOBAL TOMOSYNTHESIS MARKET, FOR 2D/3D COMBO, BY REGION, 2019–2035 (USD MILLION) 53
TABLE 4 GLOBAL TOMOSYNTHESIS MARKET, FOR 3D-ONLY, BY REGION, 2019–2035 (USD MILLION) 54
TABLE 5 GLOBAL TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 56
TABLE 6 GLOBAL TOMOSYNTHESIS MARKET, FOR U-ARM, BY REGION, 2019–2035 (USD MILLION) 57
TABLE 7 GLOBAL TOMOSYNTHESIS MARKET, FOR OTHERS, BY REGION, 2019–2035 (USD MILLION) 58
TABLE 8 GLOBAL TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 60
TABLE 9 GLOBAL TOMOSYNTHESIS MARKET, FOR BREAST CANCER SCREENING, BY REGION, 2019–2035 (USD MILLION) 61
TABLE 10 GLOBAL TOMOSYNTHESIS MARKET, FOR DIAGNOSTIC IMAGING, BY REGION, 2019–2035 (USD MILLION) 62
TABLE 11 GLOBAL TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 64
TABLE 12 GLOBAL TOMOSYNTHESIS MARKET, FOR HOSPITALS AND SPECIALTY CLINICS, BY REGION, 2019–2035 (USD MILLION) 65
TABLE 13 GLOBAL TOMOSYNTHESIS MARKET, FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2019–2035 (USD MILLION) 66
TABLE 14 GLOBAL TOMOSYNTHESIS MARKET, FOR RESEARCH & ACADEMIC INSTITUTE, BY REGION, 2019–2035 (USD MILLION) 66
TABLE 15 GLOBAL TOMOSYNTHESIS MARKET, BY REGION, 2019-2035 (USD MILLION) 67
TABLE 16 NORTH AMERICA TOMOSYNTHESIS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 69
TABLE 17 NORTH AMERICA TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 70
TABLE 18 NORTH AMERICA TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 70
TABLE 19 NORTH AMERICA TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 70
TABLE 20 NORTH AMERICA TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 71
TABLE 21 US TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 71
TABLE 22 US TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 71
TABLE 23 US TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 72
TABLE 24 US TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 72
TABLE 25 CANADA TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 72
TABLE 26 CANADA TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 73
TABLE 27 CANADA TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 73
TABLE 28 CANADA TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 73
TABLE 29 EUROPE TOMOSYNTHESIS MARKET, BY COUNTRY, 2019-2035 (USD MILLION) 75
TABLE 30 EUROPE: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 75
TABLE 31 EUROPE: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 76
TABLE 32 EUROPE: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 76
TABLE 33 EUROPE: TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 76
TABLE 34 GERMANY: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 77
TABLE 35 GERMANY: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 77
TABLE 36 GERMANY: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 77
TABLE 37 GERMANY: TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 78
TABLE 38 FRANCE: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 78
TABLE 39 FRANCE: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 78
TABLE 40 FRANCE: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 79
TABLE 41 FRANCE: TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 79
TABLE 42 UK: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 79
TABLE 43 UK: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 80
TABLE 44 UK: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 80
TABLE 45 UK: TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 80
TABLE 46 ITALY: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 81
TABLE 47 ITALY: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 81
TABLE 48 ITALY: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 81
TABLE 49 ITALY: TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 82
TABLE 50 SPAIN: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 82
TABLE 51 SPAIN: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 82
TABLE 52 SPAIN: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 83
TABLE 53 SPAIN: TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 83
TABLE 54 RUSSIA TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 83
TABLE 55 RUSSIA TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 84
TABLE 56 RUSSIA TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 84
TABLE 57 RUSSIA TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 84
TABLE 58 REST OF EUROPE TOMOSYNTHESIS MARKET, BY PRODUCT, 2019-2035 (USD MILLION) 85
TABLE 59 REST OF EUROPE TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019-2035 (USD MILLION) 85
TABLE 60 REST OF EUROPE TOMOSYNTHESIS MARKET, BY APPLICATION, 2019-2035 (USD MILLION) 85
TABLE 61 REST OF EUROPE TOMOSYNTHESIS MARKET, BY END USER, 2019-2035 (USD MILLION) 86
TABLE 62 ASIA PACIFIC TOMOSYNTHESIS MARKET, BY REGION, 2019–2035 (USD MILLION) 88
TABLE 63 ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 89
TABLE 64 ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 89
TABLE 65 ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 89
TABLE 66 ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 90
TABLE 67 CHINA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 90
TABLE 68 CHINA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 90
TABLE 69 CHINA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 91
TABLE 70 CHINA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 91
TABLE 71 INDIA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 91
TABLE 72 INDIA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 92
TABLE 73 INDIA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 92
TABLE 74 INDIA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 92
TABLE 75 JAPAN: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 93
TABLE 76 JAPAN: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 93
TABLE 77 JAPAN: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 93
TABLE 78 JAPAN: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 94
TABLE 79 SOUTH KOREA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 94
TABLE 80 SOUTH KOREA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 94
TABLE 81 SOUTH KOREA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 95
TABLE 82 SOUTH KOREA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 95
TABLE 83 MALAYSIA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 95
TABLE 84 MALAYSIA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 96
TABLE 85 MALAYSIA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 96
TABLE 86 MALAYSIA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 96
TABLE 87 THAILAND: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 97
TABLE 88 THAILAND: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 97
TABLE 89 THAILAND: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 97
TABLE 90 THAILAND: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 98
TABLE 91 INDONESIA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 98
TABLE 92 INDONESIA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 98
TABLE 93 INDONESIA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 99
TABLE 94 INDONESIA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 99
TABLE 95 REST OF ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 99
TABLE 96 REST OF ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 100
TABLE 97 REST OF ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 100
TABLE 98 REST OF ASIA PACIFIC: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 100
TABLE 99 SOUTH AMERICA TOMOSYNTHESIS MARKET, BY REGION, 2019–2035 (USD MILLION) 102
TABLE 100 SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 102
TABLE 101 SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 103
TABLE 102 SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 103
TABLE 103 SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 103
TABLE 104 BRAZIL: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 104
TABLE 105 BRAZIL: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 104
TABLE 106 BRAZIL: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 104
TABLE 107 BRAZIL: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 105
TABLE 108 MEXICO: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 105
TABLE 109 MEXICO: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 105
TABLE 110 MEXICO: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 106
TABLE 111 MEXICO: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 106
TABLE 112 ARGENTINA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 106
TABLE 113 ARGENTINA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 107
TABLE 114 ARGENTINA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 107
TABLE 115 ARGENTINA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 107
TABLE 116 REST OF SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 108
TABLE 117 REST OF SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 108
TABLE 118 REST OF SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 108
TABLE 119 REST OF SOUTH AMERICA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 109
TABLE 120 MIDDLE EAST AND AFRICA: TOMOSYNTHESIS MARKET, BY COUNTRY, 2019–2035 (USD MILLION) 111
TABLE 121 MIDDLE EAST AND AFRICA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 111
TABLE 122 MIDDLE EAST AND AFRICA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 112
TABLE 123 MIDDLE EAST AND AFRICA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 112
TABLE 124 MIDDLE EAST AND AFRICA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 112
TABLE 125 GCC COUNTRIES: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 113
TABLE 126 GCC COUNTRIES: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 113
TABLE 127 GCC COUNTRIES: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 113
TABLE 128 GCC COUNTRIES: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 114
TABLE 129 SOUTH AFRICA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 114
TABLE 130 SOUTH AFRICA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 114
TABLE 131 SOUTH AFRICA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 115
TABLE 132 SOUTH AFRICA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 115
TABLE 133 REST OF MEA: TOMOSYNTHESIS MARKET, BY PRODUCT, 2019–2035 (USD MILLION) 115
TABLE 134 REST OF MEA: TOMOSYNTHESIS MARKET, BY CONFIGURATION, 2019–2035 (USD MILLION) 116
TABLE 135 REST OF MEA: TOMOSYNTHESIS MARKET, BY APPLICATION, 2019–2035 (USD MILLION) 116
TABLE 136 REST OF MEA: TOMOSYNTHESIS MARKET, BY END USER, 2019–2035 (USD MILLION) 116
TABLE 137 PRODUCT LAUNCH 121
TABLE 138 SOFTWARE LAUNCH 122
TABLE 139 PREMARKET APPROVAL 122
TABLE 140 PRODUCT APPROVAL 122
TABLE 141 INSTALLATION 123
TABLE 142 PARTNERSHIP 123
TABLE 143 ACQUISITION 125
TABLE 144 EQUITY 126
TABLE 145 INNOVATION 126
TABLE 146 HOLOGIC, INC.: PRODUCTS OFFERED 129
TABLE 147 HOLOGIC, INC.: KEY DEVELOPMENTS 129
TABLE 148 GE HEALTHCARE: PRODUCTS OFFERED 134
TABLE 149 GE HEALTHCARE: KEY DEVELOPMENTS 135
TABLE 150 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED 139
TABLE 151 FUJIFILM HOLDINGS CORPORATION: KEY DEVELOPMENTS 139
TABLE 152 TRIVITRON HEALTHCARE PRIVATE LIMITED: PRODUCTS OFFERED 142
TABLE 153 TRIVITRON HEALTHCARE PRIVATE LIMITED: KEY DEVELOPMENTS 142
TABLE 154 PLANMED OY: PRODUCTS OFFERED 145
TABLE 155 PLANMED OY: KEY DEVELOPMENTS 146
TABLE 156 SIEMENS HEALTHINEERS: PRODUCTS OFFERED 149
TABLE 157 SIEMENS HEALTHINEERS: KEY DEVELOPMENTS 149
TABLE 158 PERKINELMER: PRODUCTS OFFERED 153
TABLE 159 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 156
TABLE 160 CANON MEDICAL SYSTEMS CORPORATION: KEY DEVELOPMENTS 156
TABLE 161 ANALOGIC CORPORATION: PRODUCTS OFFERED 160
TABLE 162 SHIMADZU CORPORATION: PRODUCTS OFFERED 163
TABLE 163 SHIMADZU CORPORATION: KEY DEVELOPMENTS 163
TABLE 164 NP JSC AMICO: PRODUCTS OFFERED 164
TABLE 165 VMI MÉDICA: PRODUCTS OFFERED 167
TABLE 166 BEMEMS CO., LTD.: PRODUCTS OFFERED 171
TABLE 167 SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD.: PRODUCTS OFFERED 172
TABLE 168 SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD.: KEY DEVELOPMENTS 173
TABLE 169 SHENZHEN LANDWIND INDUSTRY CO.: PRODUCTS OFFERED 174
TABLE 170 PAYAMED ELECTRONIC INDUSTRIES CO.: PRODUCTS OFFERED 176
TABLE 171 MEDICAL TECHNOLOGIES LTD: PRODUCTS OFFERED 178
TABLE 172 METALTRONICA S.P.A.: PRODUCTS OFFERED 180
TABLE 173 LOTUS HEALTHCARE.: PRODUCTS OFFERED 183
TABLE 174 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 175 ALLENGERS: PRODUCTS OFFERED
TABLE 176 ALLENGERS : KEY DEVELOPMENTS
TABLE 177 IMS GIOTTO S.P.A: PRODUCTS OFFERED
TABLE 178 SHENZHEN ANGELL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
TABLE 179 KONICA MINOLTA, INC.: PRODUCTS OFFERED
TABLE 180 KONICA MINOLTA, INC.: KEY DEVELOPMENTS
TABLE 181 ELECTRON CO.: PRODUCTS OFFERED